Novozymes' bioenergy delivers above expected growth
Novozymes’ sales of enzymes for bioenergy production have seen organic growth at 21% in the third quarter of 2023, and the top line in the division amounted to DKK 1,139m (USD 160.9m).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.